Evidence map›Paper›PMID 16483381›Full record

ArticleRetrovirology2006

Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants.

Gabriela Turk, Mauricio Carobene, Ana Monczor, Andrea Elena Rubio, Manuel Gómez-Carrillo, Horacio Salomón

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Frontiers in microbiology · 2017
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gabriela TurkNational Reference Center for AIDS, Department of Microbiology, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina. gturk@fmed.uba.ar
Mauricio Carobene
Ana Monczor
Andrea Elena Rubio
Manuel Gómez-Carrillo
Horacio Salomón
University of Buenos Aires · AR

Funding

UZCHS-Promote Excellence in Research and Faculty Enhanced Career Training (PERFECT Program)D43TW010137 · FIC · COLLEGE OF HEALTH SCIS UNIV OF ZIMBABWE · PI CHIPATO, TSUNGAI · 2015 to 2019
$4.1M
FIC NIH HHS 5D43 TW0010137FIC NIH HHS D43 TW010137
6 · The paper itself

Abstract

backgroundHIV-1 is characterized by its rapid genetic evolution and high diversity as a consequence of its error-prone reverse transcriptase and genetic recombination. This latter mechanism is responsible for the creation of circulating recombinant forms (CRFs) found in nature. Previous studies from our lab group have shown that the epidemic in Argentina is characterized by one highly prevalent circulating recombinant form, CRF12_BF, and many related BF recombinant forms. Since transcriptional transactivation of the HIV-1 long terminal repeat (LTR) promoter element requires the essential viral Tat protein, since these genetic structures underwent recombination in variants widely spread in South America, the aim of this work was to study transcriptional activity associated with the recombinant LTR and Tat elements.

resultsDifferential transcriptional activity was measured for the BF recombinant LTR/Tat complex that is present in widely spread viral variants was demonstrated. This analysis demonstrated a higher activity for the BF complex when compared to its B subtype counterpart.

conclusionThis study indicates structural and functional consequences of recombination events within the LTR promoter and Tat transactivator protein of a naturally occurring HIV-1 recombinant form.

Indexed as

Genetic VariationTranscriptional ActivationAcquired Immunodeficiency SyndromeAdultCell LineChildCloning, MolecularDNA, ViralGene Products, tatGenes, ReporterHIV-1HIV Long Terminal RepeatHumansRecombination, GeneticReverse Transcriptase Polymerase Chain Reactiontat Gene Products, Human Immunodeficiency VirusDNA, ViralGene Products, tattat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID16483381
PMCPMC1402313
OpenAlexW1507407662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.